Compare ABAT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABAT | NNNN |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 302.3M | 270.4M |
| IPO Year | 2013 | 2023 |
| Metric | ABAT | NNNN |
|---|---|---|
| Price | $2.19 | $4.83 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 206.4K |
| Earning Date | 11-05-2026 | 10-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $45.86 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $446.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $5.13 |
| 52 Week High | $11.49 | $44.73 |
| Indicator | ABAT | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 27.45 |
| Support Level | $2.03 | N/A |
| Resistance Level | $2.42 | $6.95 |
| Average True Range (ATR) | 0.13 | 0.58 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 34.72 | 1.75 |
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. The company also advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company focuses on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).